Ophthotech May Get Over $1 Billion From Eye Drug Deal With Novartis

Reuters

Ophthotech Corp said it could potentially receive over $1 billion in payments as part of a licensing deal for its experimental eye drug with Novartis AG.
  • <<
  • >>

Comments